Toremifene Citrate

CHEMBL1200675 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
598.1 g/mol
LogP
Phase
4

A citrate salt form of toremifene with the same therapeutic properties. This selective estrogen receptor modulator (SERM) is used to treat metastatic breast cancer in postmenopausal women whose tumors are estrogen receptor-positive.

Berat Molekul

598,1000 g/mol

TPSA

145,00 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O

InChI

InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;

Molecular Formula

C32H36ClNO8

HBD / HBA

4 / 9

Ikatan yang Dapat Dirotasi

14

Atom Berat

42

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A citrate salt form of toremifene with the same therapeutic properties. This selective estrogen receptor modulator (SERM) is used to treat metastatic breast cancer in postmenopausal women whose tumors are estrogen receptor-positive.

Yes, Toremifene Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200675. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3005572. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.